Skip to main content
Road map for treating rare diseases includes repurposing drugs
9/13/2018

Matthew Might, director of the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham, is drawing on his own experience as the parent of a child with a rare disease to create a framework for others in his situation. Might is a proponent of testing already approved drugs to see whether they work against rare diseases, though he acknowledges identifying treatments for some complex diseases is not so simple and says "there's a gap between diagnostics and therapeutics."

Full Story: